0

September 20, 2016 AT 12:30 am

National Hispanic Heritage Month: Celebrating Miguel Angel Onetti #HispanicHeritageMonth

adafruit_nationalhispanic_heritage_month_blog

Today we celebrate the brilliant Argentine-American chemist Miguel Angel Ondetti, who discovered Captorpril, a drug used to treat heart disease.

Miguel Ondetti

From World of Chemicals:

Ondetti was got many notable awards and medals in his research career like Alfred Burger Award in Medicinal Chemistry from American Chemical Society in the year of 1981, Thomas Alva Edison Patent Award, Research and Development Council in the year of 1983, Ciba Award for Hypertension Research, from American Heart Association 1983, Chairman’s Edward Robinson Squibb Award from E. R. Squibb & Sons, Inc 1986, Inventor of the Year Award from New Jersey Inventors Congress in the year of 1988, Perkin Medal from Society of Chemical Industry in the year of 1991, Warren Alpert Foundation Prize from Harvard Medical School in the year of 1991, Herman Bloch Award for Scientific Excellence in Industry from University of Chicago in the year of 1992, Lasker-DeBakey Clinical Medical Research Award in the year of 1999. Ondetti had discovered Captopril drug which is used to treat heart disease. Ondetti also had done research work on insulin peptide.

Read more here.


Check out all the Circuit Playground Episodes! Our new kid’s show and subscribe!

Have an amazing project to share? Join the SHOW-AND-TELL every Wednesday night at 7:30pm ET on Google+ Hangouts.

Join us every Wednesday night at 8pm ET for Ask an Engineer!

Learn resistor values with Mho’s Resistance or get the best electronics calculator for engineers “Circuit Playground”Adafruit’s Apps!


Maker Business — PBS Kids releases baby’s first HDMI dongle

Wearables — Spray on weather

Electronics — Switch Mode Power

Biohacking — FindAir One – Monitor Your Asthma

Get the only spam-free daily newsletter about wearables, running a "maker business", electronic tips and more! Subscribe at AdafruitDaily.com !



No Comments

No comments yet.

Sorry, the comment form is closed at this time.